HomeContact

Etex Corp.


ETEX Corporation specialises in the development of calcium phosphate-based bone graft substitutes, implant surface coatings and resorbable orthopaedic devices.


Established in 1989 by Dr. D. Duke Lee, Etex Corporation is headquartered in Cambridge, Massachusetts.


Brian T. Ennis, President & CEO
Pamela Adams, Senior VP and COO
Jerry Chang, Ph.D., Senior Director Research & Development
Steve Kim, VP and CFO
Charles J. Capps, Director, Manufacturing Operations


38 Sydney Street
Cambridge, MA 02139
USA
Phone: +1-617-577-7270
Fax: +1-617-577-7170


a-BSM, Bone Substitute Material, is a purely synthetic bone graft substitute that resorbs and is replaced with bone during the healing process. This product can be used for the treatment of bone voids. In addition, Etex is developing bone graft substitutes, which are suitable for the reconstruction of skeletal defects. Carriers for delivering recombinant human Bone Morphogenic Protein-2 (rhBMP-2) is also under development.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.

Related patents